BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32992154)

  • 1. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia).
    Ferrandina G; Aristei C; Biondetti PR; Cananzi FCM; Casali P; Ciccarone F; Colombo N; Comandone A; Corvo' R; De Iaco P; Dei Tos AP; Donato V; Fiore M; Franchi ; Gadducci A; Gronchi A; Guerriero S; Infante A; Odicino F; Pirronti T; Quagliuolo V; Sanfilippo R; Testa AC; Zannoni GF; Scambia G; Lorusso D
    Eur J Cancer; 2020 Nov; 139():149-168. PubMed ID: 32992154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy in early stage uterine sarcomas: an open question.
    Gadducci A; Romanini A
    Eur J Gynaecol Oncol; 2001; 22(5):352-7. PubMed ID: 11766739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical Mullerian adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature.
    Patrelli TS; Gizzo S; Di Gangi S; Guidi G; Rondinelli M; Nardelli GB
    BMC Cancer; 2011 Jun; 11():236. PubMed ID: 21663687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
    Dusenbery KE; Potish RA; Argenta PA; Judson PL
    Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine Adenosarcoma.
    Ulrich UA; Denschlag D
    Oncol Res Treat; 2018; 41(11):693-696. PubMed ID: 30326467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uterine sarcoma treatment].
    Köhler G
    Pathologe; 2009 Jul; 30(4):304-12. PubMed ID: 19517111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of uterine sarcomas.
    Tse KY; Crawford R; Ngan HY
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant management of operated uterine sarcomas: A single institution experience.
    Cordoba A; Prades J; Basson L; Robin YM; Taïeb S; Narducci F; Hudry D; Bresson L; Chevalier A; Le Tinier F; Mirabel X; Lartigau É; Penel N; Leblanc É
    Cancer Radiother; 2019 Sep; 23(5):401-407. PubMed ID: 31351809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of uterine sarcomas.
    Reichardt P
    Ann Oncol; 2012 Sep; 23 Suppl 10():x151-7. PubMed ID: 22987952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The retrospective analysis of patients with uterine sarcomas: A single-center experience.
    Terek MC; Akman L; Hursitoglu BS; Sanli UA; Ozsaran Z; Tekindal MA; Dikmen Y; Zekioglu O; Ozsaran AA
    J Cancer Res Ther; 2016; 12(1):309-13. PubMed ID: 27072256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
    Odunsi K; Moneke V; Tammela J; Ghamande S; Seago P; Driscoll D; Marchetti D; Baker T; Lele S
    Int J Gynecol Cancer; 2004; 14(4):659-64. PubMed ID: 15304162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine Adenosarcoma: a Review.
    Nathenson MJ; Ravi V; Fleming N; Wang WL; Conley A
    Curr Oncol Rep; 2016 Nov; 18(11):68. PubMed ID: 27718181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases].
    Han XY; Xiang Y; Guo LN; Sheng K; Wan XR; Huang HF; Pan LY
    Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):44-7. PubMed ID: 20211067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)" [Eur J Canc. vol. 139 November (2020) Pages 149-168].
    Ferrandina G; Aristei C; Biondetti PR; Cananzi FCM; Casali P; Ciccarone F; Colombo N; Comandone A; Corvo' R; De Iaco P; Dei Tos AP; Donato V; Fiore M; Franchi ; Gadducci A; Gronchi A; Guerriero S; Infante A; Odicino F; Pirronti T; Quagliuolo V; Sanfilippo R; Testa AC; Zannoni GF; Scambia G; Lorusso D
    Eur J Cancer; 2021 Feb; 144():397-398. PubMed ID: 33353792
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-Grade Endometrial Stromal Sarcoma - a Review.
    Thiel FC; Halmen S
    Oncol Res Treat; 2018; 41(11):687-692. PubMed ID: 30317238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine Adenosarcoma with Sarcomatous Overgrowth: A Case Report of Aggressive Disease in a 16-Year-Old Girl and a Literature Review.
    Liu H; Shen Z; Wu D; Zhou Y
    J Pediatr Adolesc Gynecol; 2018 Aug; 31(4):426-431. PubMed ID: 29317258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
    Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
    Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.